Global life sciences leader Thermo Fisher Scientific has announced an agreement to sell its microbiology business to European private equity firm Astorg for approximately $1.075 billion. The move is part of Thermo Fisher’s ongoing strategy to streamline its portfolio and focus on high growth, high